Insmed Inc (INSM) — 8-K Filings

8-K Filings (32)

• 8-K Filing — May 7, 2026
• INSMED Inc. Files 8-K with Regulatory Disclosures — Apr 7, 2026 Risk: low
  On April 7, 2026, INSMED Inc. filed an 8-K report detailing events under Regulation FD Disclosure, Other Events, and Financial Statements/Exhibits. The filing i
• Insmed Inc. Files 8-K on Dec 17, 2025 — Dec 17, 2025 Risk: low
  Insmed Incorporated filed an 8-K on December 17, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements. The comp
• 8-K Filing — Nov 18, 2025
• INSMED Inc. Files 8-K on Financials — Oct 30, 2025 Risk: low
  On October 30, 2025, INSMED Incorporated filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• INSMED Inc. Files 8-K Report — Aug 12, 2025 Risk: low
  On August 12, 2025, INSMED Incorporated filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regu
• INSMED Inc. Files 8-K on Operations and Financials — Aug 7, 2025 Risk: low
  On August 7, 2025, INSMED Incorporated filed an 8-K report to disclose information regarding its results of operations and financial condition. The filing also
• INSMED Inc. Files 8-K with Financials and Exhibits — Jun 13, 2025 Risk: low
  On June 11, 2025, INSMED Inc. filed an 8-K report to disclose information under Regulation FD and other events. The filing includes financial statements and exh
• INSMED Inc. Files 8-K Report — Jun 10, 2025 Risk: low
  On June 10, 2025, INSMED Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and other events, including financial statements and
• INSMED Inc. Files 8-K Report — Jun 6, 2025 Risk: low
  On June 6, 2025, INSMED Inc. filed an 8-K report detailing "Other Events." The filing does not contain specific financial transactions or material business upda
• INSMED Inc. Reports Director, Officer, and Compensation Changes — May 16, 2025 Risk: medium
  On May 15, 2025, INSMED Inc. filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensatory arrangem
• Insmed Inc. Files 8-K on Financials — May 8, 2025 Risk: low
  Insmed Incorporated filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and ex
• INSMED Inc. Announces Board and CFO Changes — Apr 17, 2025 Risk: medium
  On April 16, 2025, INSMED Incorporated announced changes in its executive leadership. The company elected two new directors, Dr. Ann M. D. Smith and Mr. David M
• INSMED Inc. Files 8-K Report — Feb 24, 2025 Risk: low
  On February 24, 2025, INSMED Incorporated filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Re
• 8-K Filing — Feb 20, 2025
• INSMED Inc. Files 8-K Report — Feb 6, 2025 Risk: low
  On February 6, 2025, INSMED Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
• Insmed Acquires Calimmune for $125M+ — Jan 10, 2025 Risk: medium
  Insmed Incorporated announced on January 10, 2025, that it has entered into a definitive agreement to acquire Calimmune, Inc. for an upfront payment of $125 mil
• Insmed Inc. Terminates Material Definitive Agreement — Nov 19, 2024 Risk: medium
  Insmed Incorporated announced on November 18, 2024, the termination of a material definitive agreement. The company, incorporated in Virginia with its principal
• Insmed Inc. Enters Material Definitive Agreement — Oct 31, 2024 Risk: medium
  Insmed Incorporated announced on October 31, 2024, that it has entered into a material definitive agreement. The company also reported its results of operations
• INSMED Inc. Files 8-K for Undisclosed Event — Aug 9, 2024 Risk: medium
  On August 9, 2024, INSMED Inc. filed an 8-K report to disclose an "Other Event." The filing does not contain specific details regarding the nature of this event
• Insmed Acquires Gene Therapy Company — Aug 8, 2024 Risk: medium
  Insmed Incorporated announced on August 8, 2024, that it has completed the acquisition of a gene therapy company for an undisclosed amount. This strategic move
• Insmed Inc. Announces Definitive Acquisition Agreement — Jul 3, 2024 Risk: medium
  Insmed Incorporated announced on July 3, 2024, that it has entered into a definitive agreement to acquire. This acquisition is expected to expand Insmed's pipel
• INSMED Inc. Files 8-K for Financial Statements — Jun 27, 2024 Risk: low
  On June 27, 2024, INSMED Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other si
• INSMED Inc. Files 8-K Report — Jun 13, 2024 Risk: low
  On June 12, 2024, INSMED Inc. filed an 8-K report to disclose other events. The filing does not contain specific financial figures or significant business updat
• INSMED Inc. Files 8-K Report — Jun 4, 2024 Risk: low
  On June 4, 2024, INSMED Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific fina
• Insmed to Acquire Gene Therapy Co., Secures $1B Loan — May 30, 2024 Risk: medium
  Insmed Incorporated announced on May 29, 2024, that it has entered into a definitive agreement to acquire a gene therapy company, pending customary closing cond
• INSMED Inc. Files 8-K Report — May 28, 2024 Risk: low
  On May 28, 2024, INSMED Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Other Events, along with Financial Statements and E
• INSMED Inc. Reports Board and Executive Compensation Changes — May 13, 2024 Risk: low
  On May 13, 2024, INSMED Incorporated filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the electio
• INSMED Inc. Files Current Report on Form 8-K — May 9, 2024 Risk: low
  On May 9, 2024, INSMED Inc. filed an 8-K report detailing its financial results and other events. The company, incorporated in Virginia with its principal execu
• INSMED Inc. Files 8-K Report — Mar 11, 2024 Risk: medium
  On March 8, 2024, INSMED Inc. filed an 8-K report to disclose "Other Events." The filing does not contain specific details about the nature of these events, dol
• INSMED Reports Material Agreements & Financial Condition — Feb 22, 2024 Risk: medium
  INSMED Incorporated filed an 8-K on February 22, 2024, reporting on an entry into a material definitive agreement, the termination of a material definitive agre
• INSMED Files 8-K for Communications, Signals Potential Event — Jan 5, 2024
  INSMED Inc. filed an 8-K on January 5, 2024, primarily to satisfy filing obligations related to written communications under Rule 425 of the Securities Act and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX